Table 2 Graves’ disease characteristics in euthyroid premenopausal vs postmenopausal patients
G-Pre-MP (n = 30) | G-Pos-MP (n = 27) | p | |
|---|---|---|---|
Age of beginning of the disease (years) | 30.0 ± 7.7 | 40.9 ± 11.0 | 0,0007 |
Time of hyperthyroidism (months) | 38,5 ± 44,9 | 53,7 ± 88,0 | ns |
Time of euthyroidism (months) | 70,6 ± 68,2 | 146,8 ± 126,9 | 0,007 |
Time of evolution of disease (months) | 98,8 ± 80,5 | 198,9 ± 130,0 | 0,002 |
Euthyroid patients with T4 (%) | 60 | 93 | 0,003 |
T4 (ug/dL) | 9,2 ± 2,2 | 9,8 ± 1,8 | ns |
TSH (uUI/mL) | 1,4 ± 1,4 | 1,6 ± 1.3 | ns |
TRAb (%) | 22,4 ± 19,0 | 21,5 ± 21,7 | ns |
PositiveTRAb patients (%) | 45 | 34 | ns |